Search research articles
Contact Us
Filters
Showing results (341-350 of 436) with videos related to
Page
of 44
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 12, 2012
Immune-mediated loss of transgene expression from virally transduced brain cells is irreversible, mediated by IFNγ, perforin, and TNFα, and due to the elimination of transduced cells
Jeffrey M Zirger, Mariana Puntel, Josee Bergeron, et al.
Oncoimmunology
|
July 12, 2021
A novel miR1983-TLR7-IFNβ circuit licenses NK cells to kill glioma cells, and is under the control of galectin-1
Diana Shah, Andrea Comba, Syed M Faisal, et al.
Frontiers in Oncology
|
August 23, 2021
Uncovering Spatiotemporal Heterogeneity of High-Grade Gliomas: From Disease Biology to Therapeutic Implications
Andrea Comba, Syed M Faisal, Maria Luisa Varela, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 27, 2004
Inflammatory and anti-glioma effects of an adenovirus expressing human soluble Fms-like tyrosine kinase 3 ligand (hsFlt3L): treatment with hsFlt3L inhibits intracranial glioma progression
Sumia Ali, James F Curtin, Jeffrey M Zirger, et al.
Journal of Virology
|
February 22, 2008
High-capacity adenovirus vector-mediated anti-glioma gene therapy in the presence of systemic antiadenovirus immunity
Gwendalyn D King, A K M Ghulam Muhammad, Weidong Xiong, et al.
Biorxiv : the Preprint Server for Biology
|
April 10, 2026
Targeting NF-κB epigenetic activation and DNA repair deficiency in G34-mutant pediatric diffuse hemispheric glioma with nanoparticles combining PARP inhibition and immune stimulation mediated by CpG dinucleotides
Santiago Haase, Kaushik Banerjee, Anzar Abdul Mujeeb, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
May 13, 2008
Regulated expression of adenoviral vectors-based gene therapies: therapeutic expression of toxins and immune-modulators
James F Curtin, Marianela Candolfi, Mariana Puntel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 9, 2017
Flt3L in Combination With HSV1-TK-mediated Gene Therapy Reverses Brain Tumor-induced Behavioral Deficits
Gwendalyn D King, Kurt M Kroeger, Catherine J Bresee, et al.
Neuro-Oncology
|
May 20, 2020
Erratum: Fyn tyrosine kinase, a downstream target of receptor tyrosine kinases, modulates antiglioma immune responses
Andrea Comba, Patrick J Dunn, Anna E Argento, et al.
Discovery Medicine
|
November 2, 2010
Gene therapy and virotherapy: novel therapeutic approaches for brain tumors
Kurt M Kroeger, A K M Ghulam Muhammad, Gregory J Baker, et al.
Page
of 44
Search research articles
Search
Showing results (341-350 of 436) with videos related to
Sort By:
Page
of 44
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 12, 2012
Immune-mediated loss of transgene expression from virally transduced brain cells is irreversible, mediated by IFNγ, perforin, and TNFα, and due to the elimination of transduced cells
Jeffrey M Zirger, Mariana Puntel, Josee Bergeron, et al.
Oncoimmunology
|
July 12, 2021
A novel miR1983-TLR7-IFNβ circuit licenses NK cells to kill glioma cells, and is under the control of galectin-1
Diana Shah, Andrea Comba, Syed M Faisal, et al.
Frontiers in Oncology
|
August 23, 2021
Uncovering Spatiotemporal Heterogeneity of High-Grade Gliomas: From Disease Biology to Therapeutic Implications
Andrea Comba, Syed M Faisal, Maria Luisa Varela, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 27, 2004
Inflammatory and anti-glioma effects of an adenovirus expressing human soluble Fms-like tyrosine kinase 3 ligand (hsFlt3L): treatment with hsFlt3L inhibits intracranial glioma progression
Sumia Ali, James F Curtin, Jeffrey M Zirger, et al.
Journal of Virology
|
February 22, 2008
High-capacity adenovirus vector-mediated anti-glioma gene therapy in the presence of systemic antiadenovirus immunity
Gwendalyn D King, A K M Ghulam Muhammad, Weidong Xiong, et al.
Biorxiv : the Preprint Server for Biology
|
April 10, 2026
Targeting NF-κB epigenetic activation and DNA repair deficiency in G34-mutant pediatric diffuse hemispheric glioma with nanoparticles combining PARP inhibition and immune stimulation mediated by CpG dinucleotides
Santiago Haase, Kaushik Banerjee, Anzar Abdul Mujeeb, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
May 13, 2008
Regulated expression of adenoviral vectors-based gene therapies: therapeutic expression of toxins and immune-modulators
James F Curtin, Marianela Candolfi, Mariana Puntel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 9, 2017
Flt3L in Combination With HSV1-TK-mediated Gene Therapy Reverses Brain Tumor-induced Behavioral Deficits
Gwendalyn D King, Kurt M Kroeger, Catherine J Bresee, et al.
Neuro-Oncology
|
May 20, 2020
Erratum: Fyn tyrosine kinase, a downstream target of receptor tyrosine kinases, modulates antiglioma immune responses
Andrea Comba, Patrick J Dunn, Anna E Argento, et al.
Discovery Medicine
|
November 2, 2010
Gene therapy and virotherapy: novel therapeutic approaches for brain tumors
Kurt M Kroeger, A K M Ghulam Muhammad, Gregory J Baker, et al.
Page
of 44